I’m thinking what can we take away so far in regards to Phelan McDermid trial As you mentioned no adverse reactions Interestingly there is no mention of adverse reactions and any are not attributable to the medication. Does this mean diarrhoea is not going to be an issue? 3 rolling groups of 20 - open label - continues to progress. Preparation for phase III is underway The trial is open label - but can not report on efficacy. So the question is - Would Neuren continue with the trial (3 progressing groups) and start preparations for phase III if efficacy data was not warranting it? I don’t think so…..
NEU Price at posting:
$14.16 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)